What’s cooking in the IPO kitchen? Poolbeg, Proposed AIM listing and demerger from Open Orphan (ORPH.L). Funds raised as part of Admission will be used primarily to fund the clinical trial costs associated with the development of the Company’s POLB 001 asset as a treatment for severe influenza and to acquire and develop new portfolio assets. Offer details and timing TBA Wise, the Fintech and payments start-up is planning to pull the trigger on a direct listing on the London Stock Exchange as s ....